昌吉 流产去哪家医院(昌吉阳痿早泄) (今日更新中)

BEIJING, Dec. 30 (Xinhua) -- China's quality watchdog said Friday that the latest checks by testing organizations did not find excessive levels of aflatoxin in milk products made by Chinese dairies.The special checks were launched after the General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ) reported on Dec. 23 that two batches of milk products made by two separate domestic dairies, including heavyweight Mengniu Dairy Group, were found to contain high levels of the cancer-causing toxin.A brief statement on the government agency's website Friday said the checks have covered major makers, including Mengniu, Yili Industrial Group, Bright Dairy, and Sanyuan Food.An AQSIQ official said earlier the toxin had originated from cows eating mildewed feed, citing reviews by experts. The toxin would disappear if the animals stop eating the rotten feed, the official said.Aflatoxin is produced by a fungus that commonly grows on crops such as grain and peanuts. High levels of the toxin may lead to cancer in some animals.

BEIJING, Oct. 18 (Xinhuanet) -- Autism can likely develop when low birth weight babies are combined with other factors such as environment and genetic predisposition, new research suggests.Researchers from the University of Pennsylvania School of Nursing and School of Medicine identified 1,105 children who weighed less than 2,000 grams at birth between Oct. 1, 1984, and July 3, 1989.Sixteen years later, researchers were able to reach 623 of those children, and used a questionnaire to screen them for autism spectrum disorders.When 189 of the children turned 21 years old, 60 percent of those who screened positive for an autism spectrum disorder, and 24 percent of those who screened negative with the condition. All in all, the rate of autism spectrum disorders among the study participants with low birth weights was five times higher than the general.Autism spectrum disorder makes people have difficulty communicating, difficulty interacting in social situations, and restrictive or repetitive interests, said study co-author Jennifer Pinto-Martin, a researcher in the University.Those with mild autism spectrum disorders, "may only want to talk about one subject," Pinto-Martin said. "They're perfectly functional. They can go to college. They can hold a job." Premature babies are often born with low birth weights, though full-term babies can also have the condition. The research suggests a need not only for better prenatal care to reduce the number of premature babies, but also a need for early diagnosis and intervention for people with autism.

WASHINGTON, Dec. 7 (Xinhua) -- Drugs that affect the levels of an important brain protein involved in learning and memory reverse cellular changes in the brain seen during aging, according to an animal study published Wednesday in the Journal of Neuroscience. The findings could one day aid in the development of new drugs that enhance cognitive function in older adults.Aging-related memory loss is associated with the gradual deterioration of the structure and function of synapses (the connections between brain cells) in brain regions critical to learning and memory, such as the hippocampus.Recent studies suggested that histone acetylation, a chemical process that controls whether genes are turned on, affects this process. Specifically, it affects brain cells' ability to alter the strength and structure of their connections for information storage, a process known as synaptic plasticity, which is a cellular signature of memory.In the current study, Cui-Wei Xie, of the University of California, Los Angeles, and colleagues found that compared with younger rats, hippocampi from older rats have less brain-derived neurotrophic factor (BDNF) -- a protein that promotes synaptic plasticity -- and less histone acetylation of the Bdnf gene. By treating the hippocampal tissue from older animals with a drug that increased histone acetylation, they were able to restore BDNF production and synaptic plasticity to levels found in younger animals."These findings shed light on why synapses become less efficient and more vulnerable to impairment during aging," said Xie, who led the study. "Such knowledge could help develop new drugs for cognitive aging and aging-related neurodegenerative diseases, such as Alzheimer's disease," she added.

SAN FRANCISCO, Nov. 11 (Xinhua) -- Logitech, a provider of personal peripherals for computers and other digital platforms, said its production of Google TV was a "big mistake," giving a major blow to Google's aspiration to change the traditional TV experience, U.S. media reported on Friday.According to technology news site The Verge, at a recent analyst and investor meeting, Logitech chief executive officer Guerrino De Luca said the launch of Logitech Revue (with Google TV set-top box) last year was "a mistake of implementation of a gigantic nature."The project cost the company more than 100 million U.S. dollars in operating profit.He said the company had "brought closure to the Logitech Revue saga" and has "no plans to introduce another box to replace Revue" after the inventory runs out this quarter.The CEO also predicted that Google TV will have a chance sometime in the future, but it would be a "grandchild of Google TV " that would do it. Logitech has no plans to help make that happen.Launched during the holiday shopping season last year, the Logitech Revue with Google TV system was criticized for being pricey and unpolished although it gives consumers a streamlined experience of traditional TV content and online media. In August, Logitech slashed the price from 249 dollars to 99 dollars.Last month, Google introduced a redesigned Google TV after sales of the first version did not meet expectations.In April, Logitech reported that Revue with Google TV set-top box and related gear only brought five million dollars in sales during the first quarter of this year, 72 percent less than the company had expected.However, support from some leading TV manufacturers may still help Google fulfill its TV plan. A Bloomberg report said Friday that Google and LG Electronics, world's second-largest TV manufacturer, may unveil a television using the search giant's software at the upcoming Consumer Electronics Show in Las Vegas.Samsung, world's largest TV manufacturer, said in February that it was in discussions with Google to develop a TV product.

BERLIN, Jan. 17 (Xinhua) -- Researchers in Germany have found a cheap and easy way to synthesize anti-malaria drug in large quantities from waste materials, said the Max Planck Society on Tuesday.Currently there are nearly one million people die worldwide each year due to lack of effective drugs, as sweet wormwood, from which artemisinin, the effective essence to fight malaria can be extracted, only grows in China, Vietnam and a few other countries.However, researchers in Germany have now developed a simple process for the synthesis of artemisinin in laboratory, using artemisinic acid, a substance contained in the by-product, or waste materials of the isolation of artemisinin from sweet wormwoods, as row materials of synthesizing artemisinin."The production of the drug is therefore no longer dependent on obtaining the active ingredient from plants," said Peter Seeberger, director at the Max Planck Institute of Colloids and Interfaces in Potsdam and professor at Free University of Berlin.The artemisinic acid in the waste material boasts a volume 10 times greater than the active ingredient itself, said Seeberger, and they could be turned into artemisinin in four and a half minutes in a so-called continuous-flow reactor.Seeberger estimated that 800 of the reactors would be enough to cover the global requirement for artemisinin, and the whole innovative synthesis process could be ready for technical use in three to six months.Malaria is a disease caused by parasites that are transmitted to people through the bites of infected mosquitoes. In 2010, malaria caused an estimated 655,000 deaths, mostly among African children.

来源：资阳报